Stage III Testicular Cancer AJCC v8

1 clinical trials · Condition

Record	Firm	Date
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors (NCT07218913)	City of Hope Medical Center	2026-02-19

Every clearance here is in the API, with alerts when new ones post.